Deborah Dunsire

Non Executive / Other Non-Executive
Login/ Register  to follow report
Company:

About

Dr Dunsire joins the board with over 30 years of experience leading large organizations in the biopharmaceutical, oncology and other speciality industries. Most recently, she retired from her role as president and chief executive officer of H. Lundbeck A/S, a biopharmaceutical company specializing in developing and delivering transformative therapies for brain diseases.  Before that, she held executive leadership roles for several pharmaceutical companies including XTuit Pharmaceuticals, FORUM Pharmaceuticals, Millennium: The Takeda Oncology Company and Millennium Pharmaceuticals.  Dr. Dunsire started her career as a primary care physician in Johannesburg, South Africa.  Dr. Dunsire currently serves on the boards of directors of Syros Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc.  She received her medical degree from the University of Witwatersrand in Johannesburg, South Africa.

 

Personal Details

Title: Dr
Surname: Dunsire
M/F: Female
Nationality: South Africa
Country of Birth: South Africa
Language: English
Qualification: M.D.
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

CompanyCommitteePositionDate Appointed
BoardMember01/09/2021

 

Working history

Name

Member

Takeda Pharmaceutical
Appointed Date: 01/01/2010
Date Resigned: 01/01/2013
Industry: Pharmaceutical

View Company

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
McKessonBoardMember01/01/2024
McKessonRemunerationMember01/01/2024
McKessonIndustry SpecificMember01/01/2024

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF